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 Neglected tropical diseases
What are the neglected 
tropical diseases?
Seventeen neglected tropical diseases 
(NTDs) have been identified by the World 
Health Organization (WHO). It is 
estimated that over 1 billion people are 
infected with NTDs, with a further 1 billion 
at risk. The majority of NTDs occur in the 
tropics and sub-tropics and have 
particular characteristics in common:
• They afflict the poorest people – those 
without access to the safe water, 
sanitation, and basic health services 
required in order to protect themselves 
against infection by bacteria, viruses 
and other pathogens. High-income 
groups are rarely affected.  
• Many are chronic, slowly developing 
conditions that become progressively 
worse if undetected and untreated. The 
damage they cause can be irreversible.
• They can cause severe pain and life-long 
disabilities, with long-term consequences 
for the person and also for family members 
who have to care for the person. 
• People with NTDs are often stigmatised 
and excluded from society, and this can 
affect their mental health. 
The individual diseases are very different, 
and one person can be affected by more 
than one disease at the same time. 
The infectious agents responsible include:
• viruses (rabies and dengue)
• bacteria (leprosy, yaws, trachoma and 
Buruli ulcer) 
• protozoa (leishmaniasis and 
trypanosomiasis)
• helminth parasites (schistosomiasis, 
lymphatic filariasis, onchocerciasis, 
intestinal worms and Guinea worm). 
Transmission is equally diverse and can 
take place via:
• flies, fomites (e.g. skin cells, hair, clothing 
or bedding) and fingers (trachoma) 
• mosquitoes (dengue fever and filariasis) 
• tsetse flies (sleeping sickness)
• sandflies (leishmaniasis) 
• blackflies (onchocerciasis)
• snails, which release infective larvae 
into water to penetrate human skin 
(e.g schistosomiasis) 
• the faeco-oral route (e.g. soil-transmitted 
helminths – see page 29) or via 
food products. 
NTDs can cause blindness (onchocerciasis 
and trachoma), deformity and disablement, 
disfigurement, cancers, and neurological 
problems.
David Molyneux
Emeritus Professor: Centre for Neglected 
Tropical Diseases, Liverpool School of 
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In 1988, Merck in the USA made Mectizan 
available at no cost to communities with 
onchocerciasis infection. The commitment 
was 'as much as is needed for as long as 
it is needed.'
This game-changing donation heralded 
the development of a new global 
partnership in health between the 
pharmaceutical industry, UN agencies, 
national ministries of health, non-govern-
mental organisations and communities 
at risk – sectors of society which 
normally do not work together. Although 
they have different structures, driving 
forces, and skills, they agreed to break 
down the barriers that usually make 
them work in separate silos and to come 
together with a common vision to control 
and eliminate the specific diseases affecting 
neglected people. Two of these diseases 
– onchocerciasis and trachoma – cause 
blindness. Thanks to these ongoing 
donations, the challenge with neglected 
tropical diseases today is not so much to 
discover a treatment but rather to reach 
the very remote communities with an 
integrated, effective and sustainable 
programme of disease control. 
This edition of the Journal aims to 
inform our readers about the neglected 
tropical diseases, the communities 
affected, and the available control 
measures. Emphasis is placed on 
integration and learning from each other 
to make the programmes more effective.
About this issue
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The biological diversity of NTDs means 
that the control or elimination strategies 
also are very diverse. 
Several NTDs can be controlled by drug 
treatment (preventive chemotherapy), on 
a country or community scale, via mass 
drug administration programmes. Other 
NTDs require different approaches and 
strategies for control or elimination, 
including specialised drugs and/or vector 
control (limiting or eradicating insects – 
e.g. fl ies and bugs – that transmit the 
pathogens). 
Despite the diversity of the strategies, 
however, there are good opportunities for 
comprehensive NTD elimination and 
control programmes.
the social and economic
impact of NtDs
NTDs are a result of poverty; they also 
contribute to further poverty in those 
people affected. Indeed, the prevalence 
of some NTDs has been suggested as an 
indicator of poverty.1,2 They also have a 
wide social and economic impact:
• the loss of ability to undertake 
traditional farming practices, critical for 
survival in rural environments
• the loss of ability to play an economic and 
social role within the family and community
• the cost of inappropriate treatment (for 
example, traditional healers), which 
enhances the cycle of poor health
and poverty 
• the loss of educational opportunities, as 
children must act as caregivers for their 
parents, creating a generation of people 
with little or no education
• poor mental health of the patient and 
the caregiver, particularly chronic 
depression.
The impact of NTDs on the unpaid work 
provided by women in the community is 
more difficult to measure. When women 
are ill, they are less able to do work such 
as growing vegetables, fetching water and 
fuel, providing care for older people and 
children, and ensuring that family 
members wash their hands or wear shoes 
 – which reduces the transmission of 
NTDs. Women tend to have poorer access 
to health care than men and are also 
disproportionately affected by some 
NTDs, such as trachoma.3
Why are NtDs receiving
increased international 
recognition?
Over the last decade, NTDs have received 
increased recognition. This was made 
possible thanks to the establishment of 
NTDs as a ‘brand’ in global health. 
It was diffi cult to focus the world’s 
attention on 17 very different diseases 
requiring a range of different interventions. 
By recognising what these diseases had in 
common, and grouping them together 
under the NTD ‘brand’, however, it 
became possible to construct compelling 
arguments for action at the international 
level. These arguments were supported 
by good evidence: that addressing NTDs 
is cost effective in terms of economic 
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rates of return on investment of health 
dollars, leading to ‘more health, for more 
people, for fewer dollars.’4 Further, the 
relationship between NTDs and social, 
equity/equality and development issues 
means they fall within the mandate of 
development agencies, therefore meriting 
both technical and financial support. 
What is being done to 
control NtDs?
The drugs needed to treat NTDs are now 
included on the WHO 'Essential Medicines' 
list, and pharmaceutical companies are 
making them freely available to the popula-
tions in need through donation programmes. 
These programmes, together with 
increased country commitment to the 
control of NTDs and novel approaches to 
drug distribution (e.g. through 
community-directed interventions or 
school health programmes) have made it 
possible to address some NTDs 
(trachoma, onchocerciasis, lymphatic 
filariasis, soil-transmitted helminths, and 
schistosomiasis) on a massive scale, in 
what have become known as mass drug 
administration (MDA) programmes. 
Community-directed treatment has 
been developed and promoted as a 
recommended way of providing mass 
drug administration. Communities take 
responsibility for the collection, delivery, 
and reporting of drug use. This is an 
effective approach: annual treatment 
records for onchocerciasis suggest that 
some 70% of the ivermectin approved for 
use is administered to those who need it 
within a 12-month period.
Mass drug administration programmes 
bring multiple benefits, including:
• direct impact on individual health, even 
beyond the target infection
• improved community engagement in 
health programmes
• better access to health care for 
populations that had little or no access
• an improved drug supply chain 
• enhanced data management,  
monitoring, evaluation, surveillance and 
reporting systems. 
What more needs to be 
done?
The majority of countries in Africa have 
completed their NTD master plans. 
Resources must be allocated to these 
plans and countries need to commit to 
the World Health Assembly (WHA) 
Resolution5 and the WHO Road Map.6
The second WHO Report on NTDs, 
‘Sustaining the Momentum’7, was 
published recently and identified progress 
since the first report.8 It also identifies the 
challenges in the way of achieving the 
disease-specific goals. 
There is a need for rapid up-scaling in 
some of the most populous countries to 
reach the WHO targets and timelines for 
control/elimination. To address this, NTD 
partners need to:
• engage in advocacy in their country
• complete mapping
• enhance human resource capacity in 
order to deliver integrated treatments 
within the health system
• address the backlog of surgery for some 
diseases (in particular, trachoma and 
lymphatic filariasis)
• implement a new strategy in areas 
where Loa loa (tropical eye worm) is 
co-endemic with lymphatic filariasis. 
This is due to the problems of severe 
reactions to ivermectin when people have 
high parasite loads of Loa loa.
Globally, the investment required for the 
delivery of donated drugs is estimated at 
around US $0.50 per person treated, per 
year. Included in this ‘unit cost’ is the cost 
of training, social mobilisation, evaluation 
and monitoring, and surveillance, all of 
which are needed for mass drug adminis-
tration programmes to be effective. The 
unit cost is estimated to be even lower in 
some settings: around US $0.10 –0.20 
per person treated, per year. Even in the 
poorest countries, this represents just a 
small fraction of the national per capita 
health expenditure.
Conclusion
Programmes to eliminate and control 
NTDs address issues of equity (equal 
access to health care) and are interven-
tions that directly benefit the poor. The 
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• On 27th May 2013, the WHA passed a resolution on all 17 neglected tropical 
diseases (Resolution WHA 66.20).5
• NTDs have been included in the post-2015 Development Agenda.9 Goal 4e 
states: 'Reduce the burden of disease from HIV/AIDS, tuberculosis, malaria, 
neglected tropical diseases, and priority-non communicable diseases.'
• In early 2012, the London Declaration10 was endorsed by 77 companies and 
organisations. The declaration included an increased commitment to drug 
donations and product development research to support the World Health 
Organization (WHO) Road Map5 towards the specific 2012–2020 NTD targets. 
• USAID and the UK Department for International Development have increased 
their support for the elimination of NTDs, and the Bill & Melinda Gates Foundation 
has committed significant research funds to address operational and product-
oriented research for NTDs.
Action on neglected tropical diseases at the global level
Table 1. The 17 neglected tropical 
diseases, as defined by the World Health 
Organization
Buruli ulcer 
(Mycobacterium ulcerans infection)
Chagas disease
Dengue/severe dengue
Dracunculiasis 
(Guinea-worm disease)
Food-borne trematodiases and 
fascioliasis (liver flukes)
Human African trypanosomiasis 
(sleeping sickness)
Human echinococcosis 
(hydatid disease)
Leishmaniasis
Leprosy
Lymphatic filariasis
Onchocerciasis 
(river blindness)
Rabies
Schistosomiasis (bilharzia)
Soil-transmitted helminthiases
taeniasis/cysticercosis 
(tapeworms)
trachoma
yaws (endemic treponematoses)
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The Gambia. People conducting a 
population-based survey randomly 
selected the hamlet of Tunku. The survey 
team waded across flooded paddy fields, 
constantly asking for directions. Tunku 
turned out to be a cluster of five mud huts 
perched on a hill on the bank of the River 
Gambia. The team found two families and 
one blind old woman there. The villagers 
could only reach their homes from the 
river using dugout canoes, and they grew 
their crops in fields that flooded. Why 
would anyone choose to live here, in this 
‘end of the road’ place? 
Nigeria. Ibadan is an 
ancient city that grew 
around its traditional 
palace. Out of the city’s 
overcrowded and labyrin-
thine streets, weeping 
mothers streamed daily to 
the tertiary teaching 
hospital less than half an 
hour away with children 
dying or dead from 
diseases such as malaria, diarrhoea, or 
marasmus. In the hospital, they saw 
clean wards with crisp white bed sheets 
— an unimaginable and unattainable 
luxury for them in their homes. Meanwhile, 
medical students ventured in the opposite 
direction, through the same labyrinthine 
depths and into homes in which gutters 
with filthy waste water ran through the 
middle of rooms and the latrine was just 
outside the window. Their purpose? A 
paediatric posting, but the challenges 
they found in these urban slums 
demanded a public health approach. Their 
traditional doctor’s training was powerless 
in the face of such challenges. 
Nairobi, Kenya. Known as a cantan-
kerous old woman, she lived alone in a 
large house in the expensive part of town. 
The house and garden had seen better 
days. Someone came in to drop her daily 
meal and rushed out because of the 
strong smell of decay and the madness of 
the old woman. When she was found 
unable to walk because of a fall in her 
kitchen and forced to go to the clinic, it 
was discovered that she had blinding 
cataracts; her poor vision at least one of 
the causes of her apparent self-neglect. 
She epitomised neglect by self and by 
others – even in the absence of poverty.
Like the people in Tunku and in the slums 
around Ibadan, poor and/or remote 
communities around the 
world – whether rural or 
urban – are often 
neglected, whether in 
Africa, the Amazon, 
Australia or the Indian 
sub-continent. However, 
neglected people can even 
be found in affluent 
communities.
If we want to address 
neglected tropical diseases 
(NTDs), we have to focus on the commu-
nities affected. As David Molineux writes 
on pages 21–24, NTDs affect people who 
are neglected in a variety of ways: through 
poverty and lack of access to basic water 
and sanitation, health services, and 
education ... In fact, just about every 
facet of development.  
How can eye care programmes 
respond to the challenge of reaching 
these neglected people? Here are some 
examples of different strategies.
sri Lanka: into every home
Midwives, who function as family health 
workers, form the backbone of health 
service delivery in Sri Lanka. In 2000, there 
were over 5,000 midwives in the country, 
each responsible for between 3,000 and 
4,000 people. This network should – in 
theory – reach the entire population of Sri 
Lanka. In rural Sri Lanka, it was noted at a 
Sightsavers review of primary eye care in 
2010, that the midwives are welcomed 
into people's homes and know every 
household and family member intimately: 
the child whose Road to Health chart is 
kept by his literate mother (Sri Lanka has 
a 98% literacy rate), the grandfather with 
hypertension, and the grandmother 
reluctant to wear her glasses. One even 
helped a father who was determined to 
NeGLeCteD CoMMuNities
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drug treatments are effective and broadly 
safe when correct policies are followed 
(see page 26). 
Mass drug administration programmes 
that reduce morbidity, mortality and trans-
mission – leading to elimination of some 
of the world’s most distressing diseases – 
should be regarded as akin to global 
immunisation when viewed from a 
strategic perspective. They have proved 
that it is possible to deliver free drugs to 
the poorest in need at unit costs that 
even some of the poorest countries can 
afford, and have already afforded. We 
must call for this successful intervention 
to be made available to everyone who 
needs treatment. If this relatively easy 
type of intervention – free drugs, no need 
for a cold chain – cannot be replicated 
and scaled up to reach everyone who 
needs treatment, worldwide, there is little 
hope that we can make a signifi cant 
impact in other priority areas, such as  
maternal and child health, or vaccinations.
The NTD community has been 
successful in achieving a paradigm shift in 
the global health community’s thinking 
about these diseases, as exemplifi ed in a 
WHA Resolution and their inclusion in the 
a post-2015 Health Goal (see panel, 
page 23). What were hitherto unpro-
nounceable conditions of poor people, 
and which did not concern high-income 
countries, are now high on the global 
health agenda. Consciousness has been 
raised but there remain many challenges, 
both technical and operational. 
A higher level of commitment is 
needed from the endemic countries, 
additional donors, non-governmental 
organisations, and charities. NTD partner-
ships recognise that they must face the 
following challenges: communicating 
the need for country commitment to 
enhance geographic and therapeutic 
coverage and improve compliance, and 
achieving this by prioritising capacity 
strengthening from the centre to the 
communities. 
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• Those at the ‘end of the road’ in 
inaccessible areas
• Migrant communities
• Those in slums: pockets of poverty in 
urban areas
• Post-disaster communities
• Communities in areas of conflict or 
in refugee camps
• Communities affected by 
environmental degradation from 
mining, climate change or bad 
development projects.
What kinds of neglected 
communities are out there?
‘NTDs affect 
people who
are neglected
in every facet
of development’
© The author/s and Community Eye Health Journal 2013. This is an Open Access article distributed under the Creative Commons Attribution Non-Commercial License.
